Wungki Park, MD MS Drew Moss MSK Department of Medicine Rohit Thummalapalli Diane Reidy-Lagunes Society for Immunotherapy of Cancer Eileen M O’Reilly Memorial Sloan Kettering Cancer Center Tae-Hyung Kim A team!!! Go Drew Moss!!! 🕺😊✨🤩

Congrats 🎊🎉🍾 @BenjcRousseau for Steven Rosenberg Award. How amazing~!! Meeting friends and alumni is always the highlight at conferences #SITC2024 MSK Department of Medicine Drew Moss Society for Immunotherapy of Cancer

Congratulations @BenjcRousseau on the award and marathon!

Huge congratulations to our rising star Drew Moss for his outstanding work at #SITC2024!

So proud !! Congratulations Rohit Thummalapalli Memorial Sloan Kettering Cancer Center NANETS

Happy thanksgiving from the call room!

BACK-TO-BACK-TO-BACK-TO-BACK!!!!!! #GoBlue

🧬KRAS mutations and biliary tract cancers JCO Precision Oncology ⭕️Mutation frequency: 15% ⭕️KRAS G12D was the most common 🚨KRAS G12 mutations ➡️ worse OS in intrahepatic CCA ❗️KRAS-targeted treatments! 👉doi.org/10.1200/PO.24.… Wungki Park, MD MS Eileen M O’Reilly OncoAlert

Michael Garcia Juelle Drew Moss MSK Department of Medicine Rohit Thummalapalli Diane Reidy-Lagunes Society for Immunotherapy of Cancer Eileen M O’Reilly Memorial Sloan Kettering Cancer Center Catherine O’Connor Tae-Hyung Kim Thank you Michael and we will never forget our stars ✨ 💜

There is still time to stop by our poster on using natural language processing to identify bleeding events! Poster #2236 at #ASH24

Excited to share our latest in Nature Medicine✨ We present a detailed clinico-genomic landscape of pancreatic adenocarcinomas With important implications for RAS 🎯 therapies Expertly co-led by Anna Varghese and Maria A Perry. w/Eileen M O’Reilly & colleagues Memorial Sloan Kettering Cancer Center

Immunotherapy replaces surgery for early-stage dMMR cancers in landmark study 🔬🧬🏥 news-medical.net/news/20250428/… #CancerResearch #Immunotherapy #ClinicalTrial #Dostarlimab #NEJM #PrecisionMedicine #Oncology #dMMRCancers NEJM Memorial Sloan Kettering Cancer Center

X-torial: Cleaning up the misinformation about Joe Biden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA National Comprehensive Cancer Network (NCCN) PCa guidelines, hold leadership in NRG Oncology National Cancer Institute

Huge congrats to Dr. Jonathan Lee Jonathan W Lee and the Memorial Sloan Kettering Cancer Center team for presenting a first-of-its-kind clinico-genomic characterization of PALB2-mutated pancreatic cancer at #ASCO25! 🧬🩺 📊 Key takeaways: — gPALB2 patients presented younger, with more family history

Congratulations and thank you ASCO for a superb International Clinical Research Scholars Program in #Addisababa #Ethiopia. It is a honor and delight to celebrate #Africa ‘s new generation of scholars unlimited enthusiasm and focused care!

Congratulations and thank you ESMO - Eur. Oncology for amplifying Memorial Sloan Kettering Cancer Center MSK Department of Medicine Layal Al Mahmasani #IDH2 in @IHC limited but valuable case series to ensure such dear patients are well taken care of!

Dr. Eileen O’Reilly (Eileen M O’Reilly) on the Rapidly Evolving Role of Local Therapy in Metastatic Pancreatic Cancer onclive.com/view/dr-o-reil… via OncLive.com

Dr. Ghassan Abou-Alfa is a renowned medical oncologist at Memorial Sloan Kettering Cancer Center. Here, he discusses the impact of cholangiocarcinoma and the role of the CCA Summit in driving research, collaboration, and improved patient care: bit.ly/4dvhGOl #CancerCare #OncologyInnovations

According to a study co-led by researchers at MSK and published in Nature Medicine, a new vaccine shows encouraging early results as a potential ready-made treatment for patients with pancreatic or colorectal cancer. Unlike individualized cancer vaccines, which are tailored to

🧵 Encouraging early results from Elicio Therapeutics KRAS-targeting vaccine in #pancreaticcancer and colorectal cancer published in Nature Medicine, feat. co-corresponding authors/PanCAN SMAB members Dr. Shubham Pant and Eileen M O’Reilly. nature.com/articles/s4159…